Related Experiment Video
Updated: Oct 9, 2026

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
Long-term results after myectomy in 64 patients with hypertrophic obstructive cardiomyopathy (HOCM). Morphological
K Minami1, H Woltersdorf, G Kleikamp
1Department of Thoracic and Cardiovascular Surgery, Heart Center NRW, Bad Oeynhausen, University of Bochum, Germany.
Insights
Transaortic myectomy significantly improves symptoms and hemodynamics in patients with hypertrophic obstructive cardiomyopathy (HOCM). This procedure offers a safe and effective long-term treatment option with low mortality rates.
Area of Science:
- Cardiology
- Cardiac Surgery
- Medical Devices
Background:
- Hypertrophic obstructive cardiomyopathy (HOCM) is a condition affecting left-ventricular morphology.
- Transaortic myectomy is a surgical procedure to address HOCM.
Purpose of the Study:
- To evaluate changes in left-ventricular morphology after transaortic myectomy.
- To assess hemodynamic improvements and survival rates in HOCM patients post-surgery.
Main Methods:
- A cohort of 64 patients with isolated HOCM underwent transaortic myectomy (Morrow's technique).
- Patients were monitored for clinical symptoms, echocardiographic pressure gradients, and survival over a mean of 4.6 years.
Main Results:
- Significant improvement in clinical symptoms (NYHA grade) and reduction in left-ventricular to aortic pressure gradients.
- Low perioperative mortality (1.6%) and favorable long-term survival rates (76.64% at 12 years).
- Recurrence of HOCM occurred in 2 patients, managed with catheter intervention.
Conclusions:
- Transaortic myectomy is a safe and effective therapy for HOCM.
- The procedure demonstrates low perioperative mortality and complication rates.
- It offers reliable long-term benefits for patients with hypertrophic obstructive cardiomyopathy.
Background:
The aim of this study was to observe the changes in left-ventricular morphology, the improvement in hemodynamics and the survival curves (according to Kaplan-Meier) of patients following transaortic myectomy.
Methods:
From November 1985 to August 1997, transaortic myectomy according to Morrow's proposal was carried out at the Heart Center NRW in Bad Oeynhausen in 64 patients with isolated HOCM. At the time of operation, the patient group included 33 women and 31 men aged between 14 and 76 years (mean 52.56 years). A hemodynamically relevant aortic stenosis was excluded in all patients. Sixty-three patients (98.4%) were evaluated in total over a mean observation period of 4.6 years (4 months to 12 years). One patient lost touch with our hospital
Results:
The clinical symptoms according to NYHA grade could be improved postoperatively from 3.4 +/- 0.33 to 1.36 +/- 0.6 (p < 0.001). The echocardiographic preoperative pressure gradient between the left ventricle and the aorta was 73.2 +/- 14.8 mmHg at rest and 139.6 +/- 21.2 mmHg after provocation by ventricular premature beats (VPBs). Postoperatively, the gradient was reduced significantly: 13.56 +/- 2.7 mmHg at rest and 23.3 +/- 10.7 mmHg after VPBs, respectively (p < 0.001). Perioperative complications occurred in 12 patients including 1 early death due to low-output syndrome, corresponding to an early mortality rate of 1.6%. Four patients died within a postoperative period of 1 year to 9.5 years, none of them due to cardiac causes, 2 due to non-cardiac causes and 1 of unknown causes. In 2 patients a recurrent HOCM occurred at 7 and 10 years after the myectomy and they were treated by catheter intervention with the alcohol induced septal infarction.
Conclusions:
Based on the 12-year survival rate of 76.640% in our study, transaortal myectomy according to Morrow represents a safe and reliable form of therapy, with relatively low perioperative mortality and complication rates, also in the long-term
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy VI: Nursing Management

